Sezen Atasoy

Sezen Atasoy

Auto-generated profile, based on publicly available information

Sezen Atasoy

Bezmialem Vakif University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2020 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
POPinar Sinem Omurtag Ozgen
Pinar Sinem Omurtag Ozgen
SASezen Atasoy
Sezen Atasoy
BKBelma Zengin Kurt
Belma Zengin Kurt
ZDZehra Durmus
Zehra Durmus
GYGulsah Yigit
Gulsah Yigit
ADAydan Dag
Aydan Dag
Carbon-based nanomaterials (CNMs) have attracted great attention in biomedical applications such as cancer imaging and therapy. CNMs, which are currently used in a wide range of applications, suffer from drawbacks of toxicity and low biocompatibility. Either noncovalent or covalent functionalization of CNMs with hydrophilic and biocompatible polymers which help to block hydrophobic interactivity between CNMs and cells can greatly increase their biocompatibility by eliminating their probable toxicity towards living organisms. In this report, we present a comparison of both noncovalent and covalent functionalization approaches in order to introduce a biocompatible glycoblock copolymer onto multi-walled carbon nanotubes (CNTs) in order to enhance their potential in therapies. An anticancer drug (doxorubicin, Dox) was conjugated with two different end functionalized poly(1-O-methacryloyl-β-D-fructopyranose-b-(2-methacryloxyethoxy))benzaldehyde glycoblock copolymers, which were synthesized via reversible addition–fragmentation chain transfer (RAFT) polymerization, by either noncovalent or covalent tethering. CNTs were coated separately with the synthesized drug-conjugated glycoblock copolymers and folic acid (FA) to obtain an efficient drug delivery platform for dual-targeting of glucose transporter protein (GLUT5) and folic acid receptors (FR) in breast cancer. A library of synthesized monomers, polymers and prepared glycoblock copolymer coated CNTs (hybrid-CNTs) using both approaches were comprehensively characterized by various techniques. Transmission electron microscopy measurements showed the homogeneous, smooth morphology of the prepared Dox-conjugated glycoblock copolymer coating of CNTs and confocal laser scanning microscopy images displayed successful cellular internalization of hybrid-CNTs in the MCF-7 and MDA-MB-231 human breast cancer cell lines. This research demonstrates the potential of hybrid-CNTs as a biocompatible drug delivery system as well as in vitro use of Dox-conjugated vehicles for dual receptor mediated breast cancer therapy.

1 April 2021 in Biomacromolecules
Verified
Journal Article
Closed access
ADAydan Dag
Aydan Dag
ECEda Cakilkaya
Eda Cakilkaya
POPinar Sinem Omurtag Ozgen
Pinar Sinem Omurtag Ozgen
SASezen Atasoy
Sezen Atasoy
GEGulsah Yigit Erdem
Gulsah Yigit Erdem
AGAyşe Gül Gürek
Ayşe Gül Gürek

1 August 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
ESEce Sevgi
Ece Sevgi
ADAydan Dag
Aydan Dag
ÇKÇağla Kızılarslan-Hançer
Çağla Kızılarslan-Hançer
SASezen Atasoy
Sezen Atasoy
BKBelma Zengin Kurt
Belma Zengin Kurt
ÖAÖznur Aksakal
Öznur Aksakal

17 July 2019 in Biomacromolecules
Verified
Journal Article
Closed access
ADAydan Dag
Aydan Dag
POPinar Sinem Omurtag Ozgen
Pinar Sinem Omurtag Ozgen
SASezen Atasoy
Sezen Atasoy

27 September 2020 in Organic Communications
Verified
Journal Article
Closed access
HŞHalil ŞENOL
Halil ŞENOL
KÇKübra Çokuludağ
Kübra Çokuludağ
AAAsude Sena Aktaş
Asude Sena Aktaş
SASezen Atasoy
Sezen Atasoy
ADAydan Dağ
Aydan Dağ
GTGülaçtı Özge TOPÇU
Gülaçtı Özge TOPÇU
In this study, 12 new oleanane and ursane derivative triterpene compounds, having fatty acids in the form of esters with carbon numbers of 12, 13, 18, 19, 24 and 25, were synthesized starting from natural products oleanolic and ursolic acids. Initially, 3-methylerythrodiol (3β-methoxyolean-12-en-28-ol) and 3-methyluvaol (3β-methoxyurs-12-en-28-ol) were synthesized from oleanolic acid and ursolic acid, respectively. For this purpose, secondary OH group at C-3 of oleanolic and ursolic acids were protected as methyl ether and, then, their carboxylic acid moieties were reduced by aluminum hydride. New fatty acid derivatives 5a-f and 8a-f were synthesized through the reaction of 3-methylerythrodiol/3-methyluvaol and corresponding fatty acid halides. In vitro cytotoxic activities of the all synthesized compounds were investigated on 3T3 fibroblast cells and PC3 prostate cancer cell lines. While all the compounds showed at least 70% inhibition on PC3 prostate cancer cells at a concentration of 25 µM, they had average of 50% inhibition on 3T3 fibroblast human healthy cells at the same concentration. Compounds 5c and 8c demonstrated the least toxic effect on 3T3 fibroblast human healthy cells and the highest toxic effect on PC3 prostate cancer cells at a concentration of 12.5 µM. Moreover, compounds 8c and 8e had the least toxic effect on 3T3 fibroblast human healthy cells and the highest toxic effect on PC3 prostate cancer cells at the same concentration.

30 August 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
SSSevde Hasanoglu Sayın
Sevde Hasanoglu Sayın
BGBeyza Goncu
Beyza Goncu
EYEmrah Yucesan
Emrah Yucesan
SASezen Atasoy
Sezen Atasoy
YKYunus Kayalı
Yunus Kayalı
NKNur Özten Kandaş
Nur Özten Kandaş
Background/ Aim: MicroRNAs (miRNAs) are known up-to-date candidate biomarkers for several diseases. In addition obtaining miRNA from different body fluids such as serum, plasma, saliva, and urine is relatively easy to handle. Herein we aimed to detect miRNAs as biomarkers for early stage prostate cancer (PC). For this purpose, we used urine and serum samples to detect any significant differences in miRNA profiles between patients and healthy controls. Total ribonucleic acid (RNA) in urine and serum samples were isolated from eight untreated PC patients and thirty healthy individuals were screened for miRNA profile and candidate miRNAs were validated. Whole urinary and serum miRNA profile was analyzed using Affymetrix GeneChip miRNA 4.0 Arrays. Candidate miRNAs were investigated by stem-loop reverse transcription - polymerase chain reaction. According to our results, when analyzed urinary samples of PC patients 49 miRNAs were detected up-regulated and 14 miRNAs were found down-regulated when compared with healthy controls. According to the serum samples 19 miRNAs were found up-regulated and 21 miRNAs were found down-regulated when compared with healthy individuals as well. Interestingly we detected overlapped only four miRNAs (MIR320A, MIR4535, MIR4706, MIR6750) that commonly increase or decrease in both serum and urine samples. Among them MIR320A was found down-regulated, and MIR4535, MIR4706, MIR6750 were found up-regulated fo urine samples. However only MIR6750 was up-regulated and the other three miRNAs were down-regulated for serum samples. Notably, the expression profile of MIR320A was significantly altered in urine specimens of prostate cancer patients. We considered that MIR320A has been evaluated as a valuable biomarker that can be used in the early diagnosis of the PC.